Factor VIII Polyclonal Antibody, FITC Conjugated
Product Specifications
Background
Factor VIII, along with calcium and phospholipid, acts as a cofactor for factor IXa when it converts factor X to the activated form, factor Xa.
Synonyms
AHF; F8B; F8C; HEMA; FVIII; DXS1253E; Coagulation factor VIII; Antihemophilic factor; Procoagulant component; F8
Gene ID
2157
Swiss Prot
P00451
Cellular Locus
Secreted, Extracellular matrix
Host
Rabbit
Cross Reactivity
Mouse
Immunogen
85-190/2351
Target
Factor VIII
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human Factor VIII
Applications
IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1µg/µl
Dilution
IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
2157
Predicted Cross Reactivity
Human, Rat, Dog, Cow, Pig, Rabbit
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PPARa, NT (Peroxisome Proliferator Activated Receptor, alpha, PPAR-alpha, Nuclear Receptor Subfamily 1 Group C Member 1, PPARA, NR1C1, PPAR) discontinued
